Sign in

CIK 0001837607

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

AEON Biopharma, Inc.

Sign in to watch
Ticker
AEON
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
853940478
Phone
+1 949-354-6499
Business address
130 VANTIS DRIVE, SUITE 170, ALISO VIEJO, CA, 92656
Former names
Priveterra Acquisition Corp.
Open-market buys, last 90 days
$57,054
in 3 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$57,054. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-17 Forth Marc Director Grant or award +222,684 973,231
2025-05-21 Forth Marc Director Grant or award · Restricted Stock Units +370,370 370,370
2024-08-31 Forth Marc CHIEF EXECTUIVE OFFICER Grant or award +470,692 750,547
2024-08-31 Forth Marc CHIEF EXECTUIVE OFFICER Grant or award · Stock Option +1,256,062 1,256,062
2024-03-19 Forth Marc CHIEF EXECTUIVE OFFICER Grant or award · Stock Option +212,466 212,466
2023-07-21 Forth Marc Chief Executive Officer Grant or award · Stock Option +970,588 970,588
2023-07-21 Forth Marc Chief Executive Officer Grant or award · Stock Option +324,021 324,021
2023-07-21 Forth Marc Chief Executive Officer Grant or award · Stock Option +291,332 291,332
2023-07-21 Forth Marc Chief Executive Officer Grant or award · Stock Option +381,480 381,480
2023-07-21 Forth Marc Chief Executive Officer Grant or award · Stock Option +194,118 194,118
2023-07-21 Forth Marc Chief Executive Officer Grant or award · Restricted Stock Units +279,855 279,855

Page 1 of 1 · 11 trades